2014
The effect of the cannabinoid CB1 receptor agonist arachidonylcyclopropylamide (ACPA) on behavioural sensitisation to methamphetamine in mice
LANDA, Leoš, Karel ŠLAIS, Alena MÁCHALOVÁ a Alexandra ŠULCOVÁZákladní údaje
Originální název
The effect of the cannabinoid CB1 receptor agonist arachidonylcyclopropylamide (ACPA) on behavioural sensitisation to methamphetamine in mice
Autoři
LANDA, Leoš (203 Česká republika), Karel ŠLAIS (203 Česká republika, domácí), Alena MÁCHALOVÁ (203 Česká republika, domácí) a Alexandra ŠULCOVÁ (203 Česká republika, garant, domácí)
Vydání
Veterinární medicína, Praha, CZECH ACADEMY AGRICULTURAL SCIENCES, 2014, 0375-8427
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.639
Kód RIV
RIV/00216224:14740/14:00075341
Organizační jednotka
Středoevropský technologický institut
UT WoS
000339609700005
Klíčová slova anglicky
behavioural sensitisation; methamphetamine; cannabinoids; ACPA; mice
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 28. 8. 2015 07:31, Olga Křížová
Anotace
V originále
The psychostimulant methamphetamine (Met), similarly to other drugs of abuse, is known to pro-duce an increased behavioural response after its repeated application (behavioural sensitisation). It has also been described that an increased response to a drug may be elicited by previous repeated administration of another drug (cross-sensitisation). We have previously shown that the CB1, CB2 and TRPV (vanilloid) cannabinoid receptor agonist methanandamide, cross-sensitised to Met stimulatory effects in mice. The present study was focused on ability of the more selective and potent CB1 receptor activator arachidonylcyclopropylamide (ACPA) to elicit cross-sensitisation to the stimulatory effects of Met on mouse locomotor behaviour in the Open field test. Male mice were randomly divided into three groups and on seven occasions (from the 7th to 13th day of the experiment) were administered drugs as follows:(a) n1: vehicle at the dose of 10 ml/kg/day; (b) n2: Met at the dose of 2.5 mg/kg/day; (c) n 3: ACPA at the dose of 1.0 mg/kg/day. Locomotor behaviour in the Open field test was measured (a) after administration of vehicle on the 1st experimental day, (b) after the 1st dose of drugs given on the 7th day, and (c) on the 14th day after drugs as follows:(a) n1: vehicle at the dose of 10 ml/kg/day; (b) n2: Met at the dose of 2.5 mg/kg/day; (c) n 3: ACPA at the dose of 1.0 mg/kg/day.
Návaznosti
ED1.1.00/02.0068, projekt VaV |
|